Altimmune's Reverse Merger Round

Altimmune raised a round of funding on January 19, 2017. Investors include PharmAthene.

Altimmune is a clinical stage biotechnology company developing immunotherapeutics and vaccines to address significant public health and biodefense needs.…

Articles about Altimmune's Reverse Merger Round: